TrialBlood2010

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS).

Timothy P Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.